Correspondence 0001193125-24-000715 from Theratechnologies Inc. (THTX) (CIK 0001512717)
Theratechnologies Inc. (THTX) (CIK 0001512717)
Date: Jan. 2, 2024 · CIK: 0001512717 · Accession: 0001193125-24-000715
AI Filing Summary & Sentiment
File numbers found in text: 333-276196
Letter
Theratechnologies Inc.
2015 Peel Street, Suite 1100
Montréal, Québec H3A 1T8
Canada
January 2, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Daniel Crawford
Re: Theratechnologies Inc.
Registration Statement on Form F-3
Filed on December 21, 2023
File No. 333-276196
Ladies and Gentlemen:
Pursuant to Rule 461 of the rules and regulations promulgated under the Securities Act of 1933, as amended, Theratechnologies Inc. (the “Registrant”) hereby respectfully requests acceleration of the effective date of the above-referenced Registration Statement on Form F-3, File No. 333-276196 (the “Registration Statement”), so that it may become effective at 4:00pm EST on January 3, 2024 or as soon thereafter as practicable.
Please do not hesitate to contact Martin C. Glass of Jenner & Block LLP at (212) 891-1672 with any questions or comments concerning this letter.
Very truly yours,
THERATECHNOLOGIES INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Theratechnologies Inc. 2015 Peel Street, Suite 1100 Montréal, Québec H3A 1T8 Canada January 2, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Daniel Crawford Re: Theratechnologies Inc. Registration Statement on Form F-3 Filed on December 21, 2023 File No. 333-276196 Ladies and Gentlemen: Pursuant to Rule 461 of the rules and regulations promulgated under the Securities Act of 1933, as amended, Theratechnologies Inc. (the “Registrant”) hereby respectfully requests acceleration of the effective date of the above-referenced Registration Statement on Form F-3, File No. 333-276196 (the “Registration Statement”), so that it may become effective at 4:00pm EST on January 3, 2024 or as soon thereafter as practicable. Please do not hesitate to contact Martin C. Glass of Jenner & Block LLP at (212) 891-1672 with any questions or comments concerning this letter. Very truly yours, THERATECHNOLOGIES INC. /s/ Jocelyn Lafond Jocelyn Lafond General Counsel and Corporate Secretary Cc: Martin C. Glass, Jenner & Block LLP